go-v.orgdoi

The Jordan Food and Drug Administration: A culture of quality and continuous improvement

Hayel Obeidat, Lina Al Kayyali, Wesal Salem Al Haqaish, Nidaa Bawaraesh, Peter J. Pitts · Journal of Commercial Biotechnology · 2014

  • DOI 10.5912/jcb671
  • Publisher OpenAlex
  • Type article
  • Issued 2014

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Commercial Biotechnology · OpenAlex · article · 2014

Abstract

In November 2013, the Jordan Food and Drug Administration, in partnership with the Center for Medicine in the Public Interest, held a seminar entitled, “Advancing the Safe Use of Drugs: Enhancing Regulatory Quality Control.” Attendees included members of the JFDA leadership as well as representatives of Jordan’s healthcare community (hospitals, pharmacists, pharmaceutical manufacturers, academics). The seminar began a strategic thinking process aimed at enhancing a regulatory environment that values pharmaceutical manufacturing quality, the importance of stakeholder involvement, the urgent role of pharmacovigilance, and greater harmonization with advanced regulatory practices.

The goal was to develop realistic recommendations that can be implemented within existing authorities and resources; that serve the Jordanian public health; and enhance the stature and reputation of the JFDA as a regional reference and a global leader.

Open the resolved locator · 10.5912/jcb671

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 04:05 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://commercialbiotechnology.com/
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.